Detailansicht

Wissensnetz

Person

Rainer Schulz (1966-)

Kardiologe

Name	Rainer Schulz
Zeit	1966- (Lebensdaten)
Ort	Gießen (Wirkungsort) Essen (Wirkungsort) Deutschland
Geschlecht	männlich
Akademischer Grad bzw. Titel	M.D. (Universitätsmedizin Essen) (1992) Dr. (Ruhr-Universität Bochum, Fakultät für Medizin)
Beruf	Kardiologe (charakteristischer Beruf) Arzt
Variante	R. Schulz
Beziehung	Justus-Liebig-Universität Gießen. Physiologisches Institut (Geschäftsführender Direktor) (2011-) Universitätsmedizin Essen (Professor) (1996-2010)
Quelle	ResearchGate: https://www.researchgate.net/profile/Rainer-Schulz-2 (Stand: 26.11.2025) https://www.uni-giessen.de/de/fbz/fb11/institute/physiologie/personal/hsl/schulz?set_language=de (Stand: 26.11.2025) AM Metadaten
Datensatztyp	Person
GND-Nummer	124940366
Datensatz-ID	124940366
Beteiligt an alle anzeigen Overexpression of Cx43: Is It an Effective Approach for the Treatment of Cardiovascular Diseases? Cardiac side effects of RNA-based SARS-CoV-2 vaccines: Hidden cardiotoxic effects of mRNA-1273 and BNT162b2 on ventricular myocyte function and structure Inhibition of MMP2 activity mitigates N-omega-nitro-l-arginine-methyl ester (l-NAME)-induced right heart failure Sex Difference in Cardioprotection against Acute Myocardial Infarction in MAO-B Knockout Mice In Vivo Thiol-based redox-active proteins as cardioprotective therapeutic agents in cardiovascular diseases Connexin 43 phosphorylation by casein kinase 1 is essential for the cardioprotection by ischemic preconditioning Connexin 43 phosphorylation by casein kinase 1 is essential for the cardioprotection by ischemic preconditioning Impact of PCSK9 on CTRP9-Induced Metabolic Effects in Adult Rat Cardiomyocytes Importance of Cx43 for Right Ventricular Function JDP2, a Novel Molecular Key in Heart Failure and Atrial Fibrillation? PI3K as Mediator of Apoptosis and Contractile Dysfunction in TGFß1-Stimulated Cardiomyocytes Autocrine effects of PCSK9 on cardiomyocytes Alterations in Glucose Metabolism During the Transition to Heart Failure: The Contribution of UCP-2 Autocrine effects of PCSK9 on cardiomyocytes Cardioprotection in right heart failure CTRP9 Mediates Protective Effects in Cardiomyocytes via AMPK- and Adiponectin Receptor-Mediated Induction of Anti-Oxidant Response Differential effects of right and left heart failure on skeletal muscle in rats Endothelial Mesenchymal Transition in Hypoxic Microvascular Endothelial Cells and Paracrine Induction of Cardiomyocyte Apoptosis Are Mediated via TGFbeta1/SMAD Signaling Influence of mental stress and environmental toxins on circadian clocks : implications for redox regulation of the heart and cardioprotection Lack of Contribution of p66shc to Pressure Overload-Induced Right Heart Hypertrophy Swiprosin-1/EFhD-2 Expression in Cardiac Remodeling and Post-Infarct Repair: Effect of Ischemic Conditioning P66shc and its role in ischemic cardiovascular diseases Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection Oxidized low-density lipoprotein (oxLDL) affects load-free cell shortening of cardiomyocytes in a proprotein convertase subtilisin/kexin 9 (PCSK9)-dependent way Physiological and therapeutic regulation of PCSK9 activity in cardiovascular disease In vivo MRI and ex vivo histological assessment of the cardioprotection induced by ischemic preconditioning, postconditioning and remote conditioning in a closed-chest porcine model of reperfused acute myocardial infarction: importance of microvasculature Mitochondrial Cx43 hemichannels contribute to mitochondrial calcium entry and cell death in the heart Epigenomic and transcriptomic approaches in the post-genomic era : path to novel targets for diagnosis and therapy of the ischaemic heart? Position paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart From basic mechanisms to clinical applications in heart protection, new players in cardiovascular diseases and cardiac theranostics: meeting report from the third international symposium on “New frontiers in cardiovascular research” ESC Working Group Cellular Biology of the Heart: Position Paper: improving the preclinical assessment of novel cardioprotective therapies Arginase induction and activation during ischemia and reperfusion and functional consequences for the heart Interaction between Connexin 43 and nitric oxide synthase in mice heart mitochondria Association of bilirubin with coronary artery calcification and cardiovascular events in the general population without known liver disease: the Heinz Nixdorf Recall study Herzmuskel im Winterschlaf : Endogene kardioprotektive Mechanismen: Myokardiales „Hibernation“ und „Ischemic Preconditioning“ Apparative Messung der Diadochokinese an einem Normalkollektiv Little Evidence for Lethal Reperfusion Injury to Cardiomyocytes Koronare Herzkrankheit : eine komplexe Erkrankung

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Rainer Schulz (1966-)

Overexpression of Cx43: Is It an Effective Approach for the Treatment of Cardiovascular Diseases?

Cardiac side effects of RNA-based SARS-CoV-2 vaccines: Hidden cardiotoxic effects of mRNA-1273 and BNT162b2 on ventricular myocyte function and structure

Inhibition of MMP2 activity mitigates N-omega-nitro-l-arginine-methyl ester (l-NAME)-induced right heart failure

Sex Difference in Cardioprotection against Acute Myocardial Infarction in MAO-B Knockout Mice In Vivo

Thiol-based redox-active proteins as cardioprotective therapeutic agents in cardiovascular diseases

Connexin 43 phosphorylation by casein kinase 1 is essential for the cardioprotection by ischemic preconditioning

Connexin 43 phosphorylation by casein kinase 1 is essential for the cardioprotection by ischemic preconditioning

Impact of PCSK9 on CTRP9-Induced Metabolic Effects in Adult Rat Cardiomyocytes

Importance of Cx43 for Right Ventricular Function

JDP2, a Novel Molecular Key in Heart Failure and Atrial Fibrillation?

PI3K as Mediator of Apoptosis and Contractile Dysfunction in TGFß1-Stimulated Cardiomyocytes

Autocrine effects of PCSK9 on cardiomyocytes

Alterations in Glucose Metabolism During the Transition to Heart Failure: The Contribution of UCP-2

Autocrine effects of PCSK9 on cardiomyocytes

Cardioprotection in right heart failure

CTRP9 Mediates Protective Effects in Cardiomyocytes via AMPK- and Adiponectin Receptor-Mediated Induction of Anti-Oxidant Response

Differential effects of right and left heart failure on skeletal muscle in rats

Endothelial Mesenchymal Transition in Hypoxic Microvascular Endothelial Cells and Paracrine Induction of Cardiomyocyte Apoptosis Are Mediated via TGFbeta1/SMAD Signaling

Influence of mental stress and environmental toxins on circadian clocks : implications for redox regulation of the heart and cardioprotection

Lack of Contribution of p66shc to Pressure Overload-Induced Right Heart Hypertrophy

Swiprosin-1/EFhD-2 Expression in Cardiac Remodeling and Post-Infarct Repair: Effect of Ischemic Conditioning

P66shc and its role in ischemic cardiovascular diseases

Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection

Oxidized low-density lipoprotein (oxLDL) affects load-free cell shortening of cardiomyocytes in a proprotein convertase subtilisin/kexin 9 (PCSK9)-dependent way

Physiological and therapeutic regulation of PCSK9 activity in cardiovascular disease

In vivo MRI and ex vivo histological assessment of the cardioprotection induced by ischemic preconditioning, postconditioning and remote conditioning in a closed-chest porcine model of reperfused acute myocardial infarction: importance of microvasculature

Mitochondrial Cx43 hemichannels contribute to mitochondrial calcium entry and cell death in the heart

Epigenomic and transcriptomic approaches in the post-genomic era : path to novel targets for diagnosis and therapy of the ischaemic heart? Position paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart

From basic mechanisms to clinical applications in heart protection, new players in cardiovascular diseases and cardiac theranostics: meeting report from the third international symposium on “New frontiers in cardiovascular research”

ESC Working Group Cellular Biology of the Heart: Position Paper: improving the preclinical assessment of novel cardioprotective therapies

Arginase induction and activation during ischemia and reperfusion and functional consequences for the heart

Interaction between Connexin 43 and nitric oxide synthase in mice heart mitochondria

Association of bilirubin with coronary artery calcification and cardiovascular events in the general population without known liver disease: the Heinz Nixdorf Recall study

Herzmuskel im Winterschlaf : Endogene kardioprotektive Mechanismen: Myokardiales „Hibernation“ und „Ischemic Preconditioning“

Apparative Messung der Diadochokinese an einem Normalkollektiv

Little Evidence for Lethal Reperfusion Injury to Cardiomyocytes

Koronare Herzkrankheit : eine komplexe Erkrankung